Klinické štúdie CHOPN v štáte Kalifornia
26 štúdií pre CHOPN hľadá účastníkov v zariadeniach v štáte Kalifornia.
Mestá v štáte Kalifornia
- Los Angeles9 štúdií
- Newport Beach8 štúdií
- San Francisco5 štúdií
- San Diego4 štúdií
- Santa Clarita3 štúdií
- Long Beach3 štúdií
- Buena Park3 štúdií
- Mountain View3 štúdií
Oficiálny text štúdie (anglicky)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Castroville
- Research Site, Garden Grove
- Research Site, Inglewood
- a 12 ďalších
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Ark Clinical Research- Site Number : 8400113, Long Beach
- Inglewood Clinical- Site Number : 8400074, Los Angeles
- Alliance Clinical - West Hills- Site Number : 8400067, Los Angeles
- a 2 ďalších
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- California Medical Research Associates Inc., Northridge
Prebieha náborFáza 2
Vek 40 až 85 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07684820A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- NewportNativeMD, Inc., Newport Beach
- Institute of HealthCare Assessment d/b/a Apex Clinical Research, San Diego
Prebieha náborFáza 2
Vek 40 až 75 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07759245Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- IMAX Clinical Trials- Site Number : 8400109, La Palma
- Long Beach Research Institute- Site Number : 8400027, Long Beach
- Downtown L.A. Research Center- Site Number : 8400009, Los Angeles
- a 3 ďalších
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07190209A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
- Newport Native MD- Site Number : 8403003, Newport Beach
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT07793409A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, Los Angeles
Prebieha náborFáza 2
Vek 40 až 80 · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT07646587A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Los Angeles
- Research Site, Newport Beach
- Research Site, Norco
Prebieha náborFáza 2
Vek 40 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of San Francisco, San Francisco
Prebieha náborFáza 2
Vek 40 a viac · Všetky pohlavia · Aktualizované 4. 9. 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Los Angeles
- Research Site, Palo Alto
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Garden Grove
- Research Site, Newport Beach
- Research Site, Torrance
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06883305A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
- Stanford Center for Excellence in Pulmonary Biology, Palo Alto
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT06603246A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- IMAX Clinical Trials, La Palma
- NewportNativeMD, Inc., Newport Beach
- California Medical Research Associates, Northridge
- a 1 ďalších
Prebieha náborFáza 2/3
Vek 35 až 80 · Všetky pohlavia · Aktualizované 31. 8. 2026 · NCT07363694A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 100, Los Angelas
Prebieha náborFáza 3
Vek 18 až 80 · Všetky pohlavia · Aktualizované 11. 8. 2026 · NCT07555483STRIVE Post-Market Registry Study
- El Camino, Taft Center for Clinical Research, Mountain View
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT04302272Multi-Center Clean Air Randomized Controlled Trial in COPD
- University of California, Los Angeles, Los Angeles
Prebieha náborFáza 3
Vek 40 a viac · Všetky pohlavia · Aktualizované 31. 7. 2026 · NCT06376994eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Newport Beach
Prebieha náborFáza 3
Vek 40 až 75 · Všetky pohlavia · Aktualizované 28. 7. 2026 · NCT07177339Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible Smokers
- San Francisco VA Medical Center, San Francisco
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 40 až 75 · Všetky pohlavia · Aktualizované 4. 6. 2026 · NCT04722835A Multi Center Study Testing a New Implant for Adults With Severe Emphysema
- University of California, San Francisco, San Francisco
Prebieha nábor
Vek 22 a viac · Všetky pohlavia · Aktualizované 3. 6. 2026 · NCT07119229The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
- UCSD Sleep Research, La Jolla
Prebieha náborFáza 2
Vek 40 až 79 · Všetky pohlavia · Aktualizované 3. 6. 2026 · NCT05237505SPIROMICS Study of Early COPD Progression (SOURCE)
- University of California Los Angeles, Los Angeles
- University of California, San Francisco, San Francisco
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 30 až 55 · Všetky pohlavia · Aktualizované 3. 6. 2026 · NCT05033990Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- University of California at Davis, Sacramento
Prebieha nábor
Vek 40 až 84 · Všetky pohlavia · Aktualizované 24. 4. 2026 · NCT06891755PiMZ Longitudinal Cohort (PiMZ Logic)
- University of California- Los Angeles, Los Angeles
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 1. 2026 · NCT06505603Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD
- Zuckerberg San Francisco General (ZSFG) Hospital, San Francisco
- Maxine Hall Health Center (MHHC), San Francisco
- Southeast Health Center (SEHC), San Francisco
Prebieha nábor
Vek 40 až 90 · Všetky pohlavia · Aktualizované 1. 12. 2025 · NCT05572632Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Science 37, Los Angeles
Prebieha náborObservačná štúdia
Vek 50 a viac · Všetky pohlavia · Aktualizované 5. 8. 2025 · NCT06122077Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap
- Arthur F Gelb MD, Lakewood
- Arthur F Gelb MD, Lakewood
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 30 a viac · Všetky pohlavia · Aktualizované 27. 10. 2023 · NCT03263130Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.